The goal of this activity is for learners to be better able to critically evaluate emerging clinical evidence on novel B-cell-modulating therapies, translate key data on proteinuria and eGFR into a practical clinical context, and establish a framework for using these biomarkers to guide longitudinal monitoring and strategic therapeutic decision-making in IgAN.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
100% of listed courses are free
300 of a sample of 300 are free · 1,252 courses listed here.
Collected from the provider’s public pages
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Breast Imaging
- Cardiovascular Disease
- Clinical Cardiac Electrophysiology
- Clinical Informatics
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Facial Plastic & Reconstructive Surgery
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Hospice & Palliative Medicine
- Hospital Medicine
- Infectious Disease
- Interventional Cardiology
- Maternal-Fetal Medicine
- Medical Genetics & Genomics
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Neonatal-Perinatal Medicine
- Nephrology
- Neurocritical Care
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Nuclear Medicine
- Obstetric Anesthesia
- Obstetrics & Gynecology
- Ophthalmology
- Otology & Neurotology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Gastroenterology
- Pediatric Neurology
- Plastic & Reconstructive Surgery
- Preventive Medicine
- Primary Care Sports Medicine
- Pulmonary Disease
- Rheumatology
- Rhinology
- Sleep Medicine
- Transplant Hepatology
- Urological Oncology
- Vascular Neurology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pain & Palliative
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Sports & Exercise Medicine
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 0.25 credits
- MOC · Up to 0.25 points
- Commercial Support
-
ReleasedJul 16, 2026
-
Last day to claim creditJul 17, 2027 9 months left
-
PeerVoice, Siyemi Europe Limited PeerVoice – 2025 Congress Highlights From Houston, Texas: A Fresh Look At The Data Driving Targeted Therapeutic Developments In IgA Nephropathy
-
PRIME Education, Inc. (PRIME®) New and Emerging Therapies in IgA Nephropathy: Latest Data and Clinical Implications
-
CMEology +1 Advancing IgA Nephropathy Care: Case-Based Perspectives and Key Insights From the ERA Congress
-
Medscape, LLC A New Chapter in IgA Nephropathy Care: Applying Evidence-Based Practices for B-Cell-Modulating Therapies
-
Medscape, LLC Navigating Advances in IgA Nephropathy: Key Developments for Therapies Targeting the B-Cell Pathway
-
Medscape, LLC New Frontiers in IgA Nephropathy: Understanding the Role of B-Cell Modulation
